Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 March 2019 | Story Ruan Bruwer | Photo Varsity Sports
Tharina van der Walt
Tharina van der Walt, a first-year student, won the hammer-throw item at the first Varsity Athletics meeting in Stellenbosch on Friday – the only gold medal for the Kovsies.

Hammer thrower Tharina van der Walt was the bright spark for the University of the Free State (UFS) at the first Varsity Athletics meeting in Stellenbosch on Friday.

Van der Walt, who recently turned 19 and is one of three first-year students in the UFS team of 25 athletes, bagged the only gold medal for the Free State students. She won the hammer throw with a distance of 53,12 m.

The UFS ended in fourth place behind NWU (first), UJ (second), and Tuks (third).

Six athletes achieved second places. Both Sokwakana Mogwasi (100 m) and Ts’epang Sello (800 m) came within a whisker of claiming victory.  Mogwasi lost the 100 m by 00:04 seconds, but in the process improved her personal best from 11,89 to 11,58. Sello (2:08,47) was in the lead for most of the 800 m but was eventually defeated by Niene Muller of Tuks by less than half a second.

Mogwasi was also second in the 200 m with a fast 24,92. Other silver medals were obtained by Yolandi Stander in the discus (52,70 m), Peter Makgato in the long jump (7,66 m), and Marné Mentz in a very fast 1500 m race. Mentz (04:26,63) chopped more than five seconds off her previous best time of 4:32,00. Her time was the third fastest ever in the 1 500 m at Varsity Athletics.

There were three third places: Sefako Mokhosoa (15,47 – triple jump), Petrus Jacobs (14,55 – 110 m hurdles), and the women’s 4x100 m relay team (Mogwasi, Elsabé du Plessis, Joviale Mbisha, and Micháela Wright).

Four athletes just missed out on podium positions, achieving fourth places.

The second Varsity athletics meeting will take place in Potchefstroom on 15 March 2019.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept